Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.80 is 80% below its 5-year average of 4.11, near the low end of its 5-year range (0.80–25.13).
As of the fiscal period ended Tuesday, June 30, 2026. 45.79% below its 12-month average of 1.48.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.80.
CURRENT RATIO
0.80
CURRENT RATIO AVG TTM
1.48
CURRENT RATIO AVG 3Y
1.90
CURRENT RATIO AVG 5Y
4.11
CURRENT RATIO AVG 10Y
3.39
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-45.79%
CURRENT VS 3Y AVG
-57.71%
CURRENT VS 5Y AVG
-80.48%
CURRENT VS 10Y AVG
-76.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-78.62%
vs the sector median at left
Market Cap
$353.88M
Current Ratio
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$355.43M
Current Ratio
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$349.70M
Current Ratio
8.26
TTM Avg
5.36
3Y Avg
5.81
5Y Avg
4.44
Market Cap
$359.53M
Current Ratio
5.85
TTM Avg
6.36
3Y Avg
5.52
5Y Avg
8.17
Market Cap
$344.04M
Current Ratio
29.52
TTM Avg
9.54
3Y Avg
9.83
5Y Avg
10.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $352.67M | 0.80 | 1.48 | 1.90 | 4.11 |
| Embecta Corp. (EMBC)vs › | $353.00M | 1.68 | 2.22 | 2.19 | 2.04 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | 3.76 | 4.71 | 6.65 | 8.92 |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 1.13 | 1.30 | 1.47 | 1.77 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 24.16 | 12.00 | 8.65 | 7.93 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | 8.26 | 5.36 | 5.81 | 4.44 |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | 1.19 | 1.21 | 1.62 | 1.62 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 5.85 | 6.36 | 5.52 | 8.17 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 29.52 | 9.54 | 9.83 | 10.59 |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 12.19 | 4.83 | 10.20 | 8.85 |
Current Ratio
0.80
Quick Ratio
0.80
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.80 |
| 2026-03-31 | 1.86 |
| 2025-12-31 | 1.06 |
| 2025-09-30 | 1.85 |
| 2025-06-30 | 1.83 |
| 2025-03-31 | 2.60 |
| 2024-12-31 | 2.86 |
| 2024-09-30 | 2.58 |
| 2024-06-30 | 1.04 |
| 2024-03-31 | 1.87 |
| 2023-12-31 | 2.51 |
| 2023-09-30 | 5.08 |
| 2023-06-30 | 5.46 |
| 2023-03-31 | 5.38 |
| 2022-12-31 | 3.45 |
| 2022-09-30 | 7.21 |
| 2022-06-30 | 11.86 |
| 2022-03-31 | 17.96 |
| 2021-12-31 | 14.66 |
| 2021-09-30 | 18.21 |
| 2021-06-30 | 25.13 |
| 2021-03-31 | 12.00 |
| 2020-12-31 | 7.16 |
| 2020-09-30 | 4.78 |
| 2020-06-30 | 3.25 |
| 2020-03-31 | 3.43 |
| 2019-12-31 | 3.47 |
| 2019-09-30 | 0.64 |
| 2019-06-30 | 4.05 |
| 2019-03-31 | 3.51 |
| 2018-12-31 | 5.71 |
| 2018-09-30 | 0.67 |
| 2018-06-30 | 0.83 |
| 2018-03-31 | 1.94 |
| 2017-12-31 | 2.15 |
| 2017-09-30 | 4.42 |
| 2017-06-30 | 4.92 |
| 2017-03-31 | 6.33 |
| 2016-12-31 | 6.20 |
| 2016-09-30 | 5.30 |
| 2016-06-30 | 2.42 |
| 2016-03-31 | 3.91 |
| 2015-12-31 | 4.91 |
| 2015-09-30 | 5.69 |
| 2015-06-30 | 6.90 |
| 2015-03-31 | 7.20 |
| 2014-12-31 | 7.13 |
| 2014-09-30 | 0.97 |
| 2014-06-30 | 1.71 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 2.03 |
| 2013-09-30 | 0.00 |
